You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Harvard Business School
McKesson
Medtronic
Baxter

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DOSTINEX

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Dostinex

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00652873 Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions Completed Anapharm Phase 1 2001-07-01 To compare the rate and extent of absorption of cabergoline 0.5 mg tablets (test) versus Dostinex (reference)
NCT00652873 Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions Completed Par Pharmaceutical, Inc. Phase 1 2001-07-01 To compare the rate and extent of absorption of cabergoline 0.5 mg tablets (test) versus Dostinex (reference)
NCT00653055 Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions Completed Anapharm Phase 1 2001-08-01 To compare the rate and extent of absorption of cabergoline 0.5 mg tablets (test) versus Dostinex (reference)
NCT00653055 Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions Completed Par Pharmaceutical, Inc. Phase 1 2001-08-01 To compare the rate and extent of absorption of cabergoline 0.5 mg tablets (test) versus Dostinex (reference)
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Dostinex

Condition Name

Condition Name for Dostinex
Intervention Trials
Nonfunctioning Pituitary Adenoma 1
Lactation Suppressed 1
Infertility 1
Endometriosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Dostinex
Intervention Trials
Disease 2
Pituitary Neoplasms 1
Pituitary Diseases 1
Adenoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Dostinex

Trials by Country

Trials by Country for Dostinex
Location Trials
Canada 2
United States 1
Brazil 1
Egypt 1
Poland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Dostinex
Location Trials
Massachusetts 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Dostinex

Clinical Trial Phase

Clinical Trial Phase for Dostinex
Clinical Trial Phase Trials
Phase 3 1
Phase 2/Phase 3 1
Phase 2 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Dostinex
Clinical Trial Phase Trials
Completed 4
Recruiting 2
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Dostinex

Sponsor Name

Sponsor Name for Dostinex
Sponsor Trials
Anapharm 2
Par Pharmaceutical, Inc. 2
Żelazna Medical Centre, LLC 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Dostinex
Sponsor Trials
Other 6
Industry 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Medtronic
Moodys
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.